New Key Statistics Module, Z-Score and F-Score
NYSE:ABT Key Ratios
Market Cap $ M | 195,616.62 |
Enterprise Value $ M | 203,151.62 |
P/E(ttm) | 35.47 |
PE Ratio without NRI | 25.27 |
Forward PE Ratio | 21.86 |
Price/Book | 4.98 |
Price/Sales | 4.83 |
Price/Free Cash Flow | 34.76 |
Price/Owner Earnings | 45.61 |
Payout Ratio % | 0.48 |
Revenue (TTM) $ M | 40,725.00 |
EPS (TTM) $ | 3.17 |
Beneish M-Score | -2.56 |
10-y EBITDA Growth Rate % | 11.80 |
5-y EBITDA Growth Rate % | 11.50 |
y-y EBITDA Growth Rate % | 2.80 |
EV-to-EBIT | 28.55 |
EV-to-EBITDA | 19.61 |
PEG | 2.20 |
Shares Outstanding M | 1,739.90 |
Net Margin (%) | 13.65 |
Operating Margin % | 15.92 |
Pre-tax Margin (%) | 15.98 |
Quick Ratio | 1.18 |
Current Ratio | 1.68 |
ROA % (ttm) | 7.63 |
ROE % (ttm) | 14.52 |
ROIC % (ttm) | 10.37 |
Dividend Yield % | 1.92 |
Altman Z-Score | 5.28 |
ABT Number of Guru Trades
ABT Volume of Guru Trades
Gurus Latest Trades with NYSE:ABT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ABT is held by these investors
Total 7
Abbott Laboratories Insider Transactions
No Available Data
News about NYSE:ABT
Total 0- 1